Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Early mortality in children with homozygous familial hypercholesterolemia : case reports of deaths at ages five and seven and a systematic review of global evidence
Authors:ID Khan, Madeeha (Author)
ID Ain, Quratul (Author)
ID Šikonja, Jaka (Author)
ID Čugalj Kern, Barbara (Author)
ID Batool, Hijab (Author)
ID Grošelj, Urh (Author), et al.
Files:.pdf PDF - Presentation file, download (1,59 MB)
MD5: 4908F28A62BC73CBA6E7ABBB4ADE269B
 
URL URL - Source URL, visit https://www.lipidjournal.com/article/S1933-2874(25)00541-0/fulltext
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Background: Homozygous familial hypercholesterolemia (HoFH) is a leading cause of premature atherosclerotic cardiovascular disease (ASCVD) and early mortality if left untreated or inadequately treated. Objective: This study presents 2 pediatric cases of early death from Pakistan due to familial hypercholesterolemia (FH) and provides a systematic review of similar cases reported globally. Methods: Genetic analysis was conducted using next-generation sequencing to confirm pathogenic variants. For the systematic review, published reports of individuals with FH who died before the age of 18 years were identified. Data were extracted on demographic features, personal and family history, genetic variants, treatment given, and cause of death. Results: Both patients, born to consanguineous families, presented with markedly elevated low-density lipoprotein cholesterol (LDL-C) levels (792 mg/dL [20.48 mmol/L] and 896 mg/dL [23 mmol/L], respectively), multiple xanthomas, and early-onset myocardial infarction, and died at the ages of 5 and 7 years, respectively. Their genetic analysis revealed a pathogenic frameshift variant in the LDLR gene: NM_000527.5: c.2416dupG (p.Val806GlyfsTer11). The systematic review included 12 studies reporting pediatric FH-related mortality. Common clinical features included tendon xanthomas, elevated LDL-C levels, family history, and early-onset ASCVD. Genetic testing was performed in a few cases, which revealed pathogenic variations in the LDLR gene. Most of the patients received inadequate lipid-lowering therapy. The most common causes of death were severe coronary artery disease, myocardial infarction, and sudden cardiac arrest. Conclusion: Our 2 cases and the accompanying systematic review identified additional cases of premature mortality. Collectively, these findings highlight diagnostic delays and inadequate treatment as common factors among patients who died prematurely.
Keywords:familial hypercholesterolemia, homozygous FH, mortality, atherosclerosis, LDLR
Publication status:Published
Publication version:Version of Record
Year of publishing:2026
Number of pages:str. 402-410
Numbering:Vol. 20, issue 2
PID:20.500.12556/DiRROS-28434 New window
UDC:616-053.2
ISSN on article:1933-2874
DOI:10.1016/j.jacl.2025.12.010 New window
COBISS.SI-ID:263378691 New window
Publication date in DiRROS:19.03.2026
Views:236
Downloads:162
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Journal of clinical lipidology
Shortened title:J. clin. lipidol.
Publisher:Elsevier
ISSN:1933-2874
COBISS.SI-ID:2753599 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-2536-2020
Name:UGOTAVLJANJE GENETSKIH VZROKOV DISLIPIDEMIJ PRI OTROCIH IN MLADOSTNIKIH TER NJIHOVO ZGODNJE ODKRIVANJE S POPULACIJSKIM PRESEJANJEM

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0343-2022
Name:Etiologija, zgodnje odkrivanje in zdravljenje bolezni pri otrocih in mladostnikih

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Back